![]() |
市場調查報告書
商品編碼
1725121
2032 年血糖值試紙包裝市場預測:按類型、材料、薄膜類型、技術、分銷管道和地區進行的全球分析Blood Glucose Test Strip Packaging Market Forecasts to 2032 - Global Analysis By Type, Material Type, Film Type, Technology, Distribution Channel and By Geography |
根據 Stratistics MRC 的數據,全球血糖值試紙包裝市場預計在 2025 年將達到 24 億美元,到 2032 年將達到 44 億美元,預測期內的複合年成長率為 8.6%。
血糖值試紙包裝是指為保持用於監測血糖值的試紙的完整性和功能性而設計的專門外殼。這些包裝可保護試紙免受潮濕、污染和外部損壞,確保讀數準確。包裝通常由耐用、防潮的材料製成,方便使用者取用,同時保持無菌。先進的設計融合了可重新密封的封蓋、獨立隔間和防篡改密封等特點,易於使用並提高安全性。
根據聯合國兒童基金會的第一個目標產品概況,在資源匱乏的環境中,獲得診斷實驗室的幫助仍然是關鍵挑戰。即時診斷測試使醫療保健專業人員能夠提供更快、更有效的護理。
增加在家檢測和遠端患者監護
隨著全球糖尿病盛行率的增加,方便、易得的血糖管理解決方案正成為優先事項。在家進行測試可以讓患者監測血糖濃度,而無需頻繁去診所,從而降低醫療成本並改善疾病管理。此外,數位健康技術的進步使得試紙包裝和智慧監控設備能夠無縫整合,從而改善用戶體驗。
複雜的製造和供應鏈要求
製造商必須遵守監管標準,以確保包裝材料不會損害測試條的完整性。此外,採購防潮膜和防篡改密封等特殊材料會增加生產成本。供應鏈中斷,例如原料短缺和運輸困難,可能會影響及時分銷,從而影響市場成長。
更加關注生物分解性或可回收材料
隨著人們對環境問題的日益關注,醫療保健產業正在轉向永續包裝解決方案以減少塑膠廢棄物。製造商正在探索環保替代品,例如生物分解性的薄膜和可回收的包裝,以實現全球永續性目標。監管機構也鼓勵採用環保包裝方法,鼓勵企業投資創新材料。此外,消費者對環境影響的認知正在影響購買決策,推動對永續醫療保健產品的需求。
更換為持續血糖監測(CGM)設備
CGM 技術提供即時血糖追蹤,無需頻繁進行指尖採血測試,減少了對傳統試紙的依賴。隨著 CGM 的應用不斷增加,尤其是那些需要高階糖尿病管理的人,對血糖值試紙的需求可能會下降。此外,醫療保健提供者青睞 CGM 設備,因為它們能夠提供全面的血糖趨勢分析,從而改善治療效果。
COVID-19 疫情以多種方式影響了血糖值試紙包裝市場,既影響了供應鏈,也影響了消費行為。雖然最初製造和物流中斷導致了暫時的供不應求,但這場危機也提高了人們對糖尿病管理的認知。患者優先考慮在家中進行檢測以盡量減少去醫院的次數,這推動了對試紙和可靠包裝解決方案的需求。隨著個人尋求便捷的監測工具,向遠端醫療和遠距醫療諮詢的轉變進一步推動了市場的成長。
預計預測期內管瓶/管部分將達到最大程度的成長。
由於試紙在儲存中的廣泛應用,預計管瓶/試管部分將在預測期內佔據最大的市場佔有率。管瓶和試管可提供卓越的防潮、防污染和防物理損壞保護,確保血糖值測量的準確性。其可重新密封的設計增加了便利性,使用戶能夠在保持無菌的同時使用測試條。
預計預測期內鋁業將以最高的複合年成長率成長。
在預測期內,鋁業預計將憑藉其優異的阻隔性能和永續性優勢實現最高的成長率。鋁包裝具有防潮功能,有助於測試紙在各種環境條件下保存更長時間。此外,它的可回收性符合人們對環保醫療保健解決方案日益成長的關注,使其成為製造商的一個有吸引力的選擇。該領域受益於輕質鋁包裝技術的進步,提高了便攜性和用戶便利性。
在預測期內,預計北美將佔據最大的市場佔有率,這得益於糖尿病的高盛行率和強大的醫療保健基礎設施。該地區擁有成熟的醫療設備產業,領先的製造商正在投資先進的封裝技術。此外,消費者對糖尿病管理和預防性醫療保健的認知正在推動對可靠的試紙包裝解決方案的需求。
由於醫療保健投資增加、糖尿病患者數量增加以及醫療設備使用範圍擴大,預計亞太地區將在預測期內實現最高的複合年成長率。中國、印度和日本等國家對血糖值監測工具的需求激增,推動了包裝創新。政府推動提高糖尿病意識和早期診斷的舉措進一步推動了市場擴張。
According to Stratistics MRC, the Global Blood Glucose Test Strip Packaging Market is accounted for $2.4 billion in 2025 and is expected to reach $4.4 billion by 2032 growing at a CAGR of 8.6% during the forecast period. Blood glucose test strip packaging refers to specialized containment designed to preserve the integrity and functionality of test strips used for monitoring blood sugar levels. These packages protect the strips from moisture, contamination, and external damage, ensuring accurate readings. Typically made from durable, moisture-resistant materials, the packaging maintains sterility while allowing easy access for users. Advanced designs incorporate features like resealable closures, individual compartments, and tamper-evident seals to enhance usability and safety.
According to the UNICEF target product profile, 1st edition, access to diagnostic laboratories remains a key challenge in low-resource settings. Point-of-care diagnostic tests enable healthcare workers to provide more rapid and effective care.
Increased home-based testing and remote patient monitoring
As diabetes prevalence rises globally, individuals are prioritizing convenient and accessible solutions for blood glucose management. Home-based testing allows patients to monitor their glucose levels without frequent hospital visits, reducing healthcare costs and improving disease management. Additionally, advancements in digital health technologies are enabling seamless integration of test strip packaging with smart monitoring devices, enhancing user experience.
Complex manufacturing and supply chain requirements
Manufacturers must adhere to regulatory standards, ensuring that packaging materials do not compromise the integrity of test strips. Additionally, sourcing specialized materials such as moisture-resistant films and tamper-evident seals adds to production costs. Supply chain disruptions, including raw material shortages and transportation challenges, can impact timely distribution, affecting market growth.
Growing focus on biodegradable or recyclable materials
As environmental concerns rise, healthcare industries are shifting toward sustainable packaging solutions to reduce plastic waste. Manufacturers are exploring eco-friendly alternatives such as biodegradable films and recyclable containers to align with global sustainability goals. Regulatory bodies are also encouraging the adoption of green packaging practices, prompting companies to invest in innovative materials. Additionally, consumer awareness regarding environmental impact is influencing purchasing decisions, driving demand for sustainable healthcare products.
Substitution by continuous glucose monitoring (CGM) devices
CGM technology offers real-time glucose tracking without the need for frequent finger-prick tests, reducing reliance on traditional test strips. As CGM adoption increases, particularly among individuals with advanced diabetes management needs, demand for blood glucose test strips may decline. Additionally, healthcare providers are advocating for CGM devices due to their ability to provide comprehensive glucose trend analysis, improving treatment outcomes.
The COVID-19 pandemic had a mixed impact on the blood glucose test strip packaging market, influencing both supply chains and consumer behavior. While initial disruptions in manufacturing and logistics led to temporary shortages, the crisis also heightened awareness of diabetes management. Patients prioritized home-based testing to minimize hospital visits, increasing demand for test strips and reliable packaging solutions. The shift toward telemedicine and remote healthcare consultations further supported market growth, as individuals sought convenient monitoring tools.
The vials/tubes segment is expected to be the largest during the forecast period
The vials/tubes segment is expected to account for the largest market share during the forecast period due to its widespread use in test strip storage. Vials and tubes provide superior protection against moisture, contamination, and physical damage, ensuring the accuracy of blood glucose readings. Their resealable design enhances convenience, allowing users to access test strips while maintaining sterility.
The aluminum segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the aluminum segment is predicted to witness the highest growth rate driven by its superior barrier properties and sustainability advantages. Aluminum packaging offers excellent moisture resistance, ensuring the longevity of test strips in various environmental conditions. Additionally, its recyclability aligns with the growing focus on eco-friendly healthcare solutions, making it an attractive option for manufacturers. The segment is benefiting from technological advancements in lightweight aluminum packaging, enhancing portability and user convenience.
During the forecast period, the North America region is expected to hold the largest market share driven by high diabetes prevalence and strong healthcare infrastructure. The region has a well-established medical device industry, with leading manufacturers investing in advanced packaging technologies. Additionally, consumer awareness regarding diabetes management and preventive healthcare is fueling demand for reliable test strip packaging solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising healthcare investments, increasing diabetes cases, and expanding access to medical devices. Countries such as China, India, and Japan are experiencing a surge in demand for blood glucose monitoring tools, driving packaging innovations. Government initiatives promoting diabetes awareness and early diagnosis are further supporting market expansion.
Key players in the market
Some of the key players in Blood Glucose Test Strip Packaging Market include Abbott, ACON Laboratories Inc., AgaMatrix, Amcor, Aptar CSP Technologies, ARKRAY Inc., Ascensia Diabetes Care, Bionime Corporation, LifeScan IP Holdings LLC, Multisorb, Procurenet Limited, Roche, Rossmax International Ltd, Sanner, Shijiazhuang Xinfuda Medical Packaging Co., Ltd., Trividia Health Inc., Wisesorbent Technology, and YuHuan KangJia.
In November 2024, Ascensia Diabetes Care, in collaboration with Fitterfly Healthtech, launched a 21-day Diabetes Management Program on World Diabetes Day. This initiative offers Ascensia glucometer users personalized support, including diet plans, AI wellness coaching, and expert guidance to simplify diabetes management.
In September 2024, Aptar CSP's N-Sorb Nitrosamine Mitigation Solution was accepted into the US FDA's Emerging Technology Program, addressing concerns related to N-nitrosamine impurities in pharmaceuticals.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.